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Abstract
Background: The 1980’s economic boom has been associated with a rapid expansion of China’s sex industry over
the past three decades. Consequently, the spread of sexually transmitted infections (STIs) and hepatitis infections among
female sex workers (FSW) has become an important public health issue in China. This study identifies prevalence and risks
of hepatitis and STIs in Chinese FSWs.
Method: Four electronic databases were searched for Chinese and English language peer-reviewed studies conducted
between 01/2000-12/2011 that reported prevalence of hepatitis and STIs (excluding HIV) among Chinese FSW. Following
the PRISMA guidelines, meta-analysis was used to estimate pooled prevalence and 95 % confidence intervals for each
infection.
Result: Three hundred and thirty nine articles (34 in English and 305 in Chinese) investigating 603,647 FSWs in 29
Chinese provinces were included in this review. Over the period 2000–2011, the seroprevalence of active hepatitis B
and hepatitis C among FSW were 10.7 % (7.3–15.5 %) and 1.0 % (0.7–1.3 %), respectively. The most prevalent STI was
human papillomavirus (HPV, 27.0 % [10.1–55.1 %]), followed by herpes simplex virus-2 (HSV-2, 15.8 % [11.7–20.9 %]),
chlamydia (13.7 % [12.1–15.4 %]), gonorrhoea (6.1 % [5.3–7.0 %]), syphilis (5.2 % [4.8–5.7 %]), genital warts (3.3 %
[2.5–4.2 %]) and Trichomonas vaginitis (2.1 % [1.5–24.2 %]). Disease burden of both hepatitis and STI among FSW
were concentrated in South Central and Southwest China. In particular, chlamydia and syphilis demonstrated a
significant declining trend during the studied period (P < 0.05). Compared with the general Chinese population,
FSW had significantly higher prevalence of all STIs except Trichomonas vaginitis. Further, compared to the general
FSW population, HIV-positive FSW had significantly higher prevalence of syphilis, chlamydia, HSV-2 and Trichomonas
vaginitis.
Conclusion: Prevalence of hepatitis and STIs remained high and mostly stable among Chinese FSW over the period of
2000–2011. Targeted STI and hepatitis surveillance and interventions should be strengthened among Chinese FSWs,
especially those who are HIV-positive.
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Background
Every year, sexually transmitted infections (STIs) affect
more than 500 million people worldwide, posing a substan-
tial threat to sexual and reproductive health of the world
population [1]. While most STIs are curable with timely
diagnosis and treatment, others lead to serious long-term
effects including reproductive complications and death.
Furthermore, individuals infected with STIs are more likely
to contract or transmit HIV, and co-infection with hepatitis
can complicate the treatment for HIV [2–4]. In response
to these concerns, the World Health Organization has rec-
ommended prevention of STIs and hepatitis as a repro-
ductive health priority [5, 6].
The 2013 statistics from the Chinese Ministry of
Health reported a rapidly rising trend in STIs since the
1979 economic reform [7, 8]. In the contexts of increas-
ingly open attitudes toward commercial sex and higher
disposable incomes, soliciting female sex workers (FSW)
is increasing in China [9, 10]. Commercial sex is illegal
in China and subjected to harsh publishment, FSWs
who are caught are sent to detention centres. Most
Chinese FSWs sell sex in concealed venues and have
established their own network to avoid being detected
by the police. Given their opaque characters, frequent
risk sexual activities and low awareness, Chinese FSWs
are regarded as a highly at-risk group for STIs [11, 12].
Hepatitis C and B are also of concern among this group
mainly due to higher rates of reported drug use (for
HCV) and unsafe sexual behaviours (for HBV) among
FSW as compared to the general population [13, 14].
Furthermore, transmission of STIs and hepatitis through
male clients of FSW may have potential adverse impacts
on the broader female population [15]. The estimated
prevalence of HIV, syphilis, chlamydia and gonorrhoea
were all higher among clients of female sex workers than
among the general population, and a systematic review
conducted in 2000–2012 demonstrated an significant in-
crease in syphilis among male clients [16].
China’s STI surveillance system routinely collects epi-
demic data of STIs only on syphilis and gonorrhoea.
The data is collected by China CDC, but most of the
data remain unpublished. Although numerous inde-
pendent studies and an earlier systematic review [17]
have reported STI and hepatitis infection burden
among FSWs across China, these data have not been
integrated to inform the overall geographic and tem-
poral trends of STI infections among FSWs. In this
study, we conducted a comprehensive data synthesis of
hepatitis and STI epidemic information to inform the
current disease burden, temporal trends and geographic
distribution of STI infections among FSWs in China.
This knowledge is important for informing HIV/STI
health policies and designing evidence-based strategies
for hepatitis and STI prevention among FSWs in China.
Methods
This meta-analysis was performed according to the
PRISMA (Preferred Reporting Items for Systematic Re-
views and Meta-Analyses) Statement issued in 2009
(Checklist S1).
Literature and search strategy
We searched one English database (PubMed) and three
Chinese databases (Wanfang Data, VIP Chinese Journal
Database and China National Knowledge Infra-structure)
for studies conducted between January 1, 2000 to Decem-
ber 31, 2011 that reported the prevalence of STIs or hepa-
titis infections among FSW in mainland China.
The search included Medical Subject Headings (MeSH)
terms for ‘China’, ‘Chinese’, ‘CSW (commercial sex
workers)’, ‘FSW’, ‘hepatitis’, ‘sexually transmitted diseases’
and ‘sexually transmitted infections’, and other keywords
associated with each STI: ‘chlamydia’, ‘Chlamydia tracho-
matis’, ‘gonorrhoea’, ‘Neisseria gonorrhoea’, ‘syphilis’, ‘genital
warts’, ‘hepatitis’, ‘HBV’, ‘hepatitis B’, ‘HCV’, ‘hepatitis C’,
‘HSV’, ‘herpes simplex virus’, ‘HPV’, ‘human papillomavirus’
and ‘trichomonas vaginitis’. Hand searching from the ref-
erence lists of the retrieved articles in the above databases
was also included. Only articles published in Chinese or
English language were included. Two reviewers (EPFC,
XHZ) independently screened all retrieved abstracts from
the four aforementioned databases to assess eligibility.
Discrepancies were resolved by discussion with a third re-
viewer (LZ).
Selection criteria
Type of studies
Eligible study designs included quantitative epidemio-
logical studies, including cohort and cross-sectional stud-
ies. The following types of publications were excluded:
news reports, review articles, conference abstracts, math-
ematical modelling studies, clinical case studies, disserta-
tions, studies with sample size less than 30 for general
FSW or less than 10 for HIV-positive FSW, and STI
prevalence reported without authenticated diagnosis
(syphilis and hepatitis prevalence without serological test).
Studies not conducted in mainland China were excluded.
Type of participants
We only included studies with FSW who self-reported
having any commercial sexual activity (sell sex for money)
in the past 12 months. There were no restrictions on age,
marital status, educational level, ethnicity or residency.
Studies that targeted HIV-positive FSW were included to
investigate the prevalence of co-infection.
Type of outcome measures
We included studies that measured the prevalence of
the most common STIs among FSW including syphilis,
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chlamydia, gonorrhoea, HPV/genital warts, HSV-2, and
Trichomonas vaginitis. We also included HBV infection
which is sexually transmitted and HCV infection which
can be transmitted through injecting drug use. Studies
were included if syphilis, chlamydia, gonorrhoea, HPV/
genital warts, HSV-2, Trichomonas vaginitis, HBV or HCV
was diagnosed and confirmed by a serological testing ap-
proach. We included published studies in which HBV in-
fection was defined by the presence of hepatitis B surface
antigen (HBsAg) as HBsAg is a serologic marker represent-
ing either acute or chronic HBV infection rather than due
to other cases such as HBV immunity; HCV infection was
diagnosed by the presence of anti-HCV antibodies; HPV
infection was tested by PCR for any of the genital HPV
types; chlamydia, gonorrhoea were tested by PCR, EIA or
cell culture; syphilis was tested by specific treponemal sero-
logical method, rapid plasma regain or PCR and any posi-
tive result was considered positive; Trichomonas vaginitis
was tested by wet mount and PCR; genital warts were clin-
ically diagnosed based on the presence of warts; HSV-2
was diagnosed by the presence of type specific Immuno-
globulin G (IgG) by EIA. Self-reported infections were ex-
cluded from this review.
Quality assessment
The authors assessed the methodological quality of every
included study using an 8-item checklist tool for obser-
vational studies [18]. Based on the checklist guidelines,
the quality of each item was categorized as either “High
quality” (1 point) or “Low quality” (0 points) for a total
possible score ranging between 0 and 8. Studies with
higher scores were regarded as higher quality.
Data extraction
Data were exported and entered into a Microsoft Excel
database (Version 2010, Microsoft Corp., Redmond, WA,
USA). Each study was given a unique ID number and the
data collection form included information on: (1) Study
design: location, sampling methods/venues, type of study,
sample size, and study year; (2) epidemiology of STIs and
hepatitis infections: prevalence estimates of STIs, HBV or
HCV, prevalence estimates of HPV gene type subgroups
and prevalence estimates of sites and biomarkers of chla-
mydia and gonorrhoea.
Statistical analysis
Pooled estimates with 95 % confidence intervals (CI) were
calculated for the prevalence of each STI and hepatitis
infection among Chinese FSW. These estimates were
expressed as a percentage (number of infections divided by
the number of individuals tested for the infection). Pooled
odds ratios (OR) with 95 % CIs were calculated by compar-
ing the pooled estimates between FSW and the general
Chinese adult population. To obtain STI prevalence for
various subgroups, we also conducted sensitivity analyses,
and stratified by geographic region (North, Northeast,
Northwest, East, South Central, Southwest), FSW venue
type (entertainment venues, national sentinel sites, detain-
ing education centres, VCT and others), sample size, lan-
guage of the publication, study quality score, and study
year (Additional file 1: Table S1 and S3). To estimate the
risk of STI acquisition in HIV-positive FSW, the pooled
OR with a 95 % CI was calculated by comparing the pooled
STI prevalence estimates among HIV-positive FSW and
general FSW. STI and hepatitis prevalence of the general
population was estimated for the Chinese population of re-
productive age (i.e. >15 years old) using data from national
or large cross-sectional studies [19–24].
Heterogeneity across included studies was assessed
using a chi-squared based Cochran’s Q test and an I2 test.
If the data showed low heterogeneity (p > 0.05, I2 < 50 %),
a fixed-effect model was used; otherwise, a random-effect
model was used. Publication bias was tested by the Begg
and Mazumdar rank correlation [25]. Geographical re-
gions with first and second highest prevalence were de-
fined as ‘high prevalence’ areas, the third and fourth ones
were defined as ‘moderate prevalence’ whereas the fifth
and sixth ones were defined as ‘low prevalence’ (Fig. 1b).
The temporal trend of STIs was tested by chi-square trend
test comparing the study periods 2000–2002, 2003–2005,
2006–2008, and 2009–2011 (Fig. 3). All meta-analyses
were performed by using the Comprehensive Meta-
Analysis (version 2.2, Biostat, Englewood, New Jersey).
Results
Characteristics of the studies
Out of the 3015 studies identified through initial searches,
339 studies (English: 34; Chinese: 305) were eligible and
included in this review (Additional file 2). The majority of
studies were cross-sectional observational studies (n =
286). Eighteen studies reported on HBV, 97 on HCV, 215
on syphilis, 96 on chlamydia, 116 on gonorrhoea, 38 on
HSV-2, 43 on Trichomonas vaginitis, 68 on genital warts
and 4 on HPV, respectively (Table 1). From these pub-
lished studies, 603,647 FSWs in 29 Chinese provinces
were included in this review. Sample size ranged from 11
to 12,363. The mean age of FSW was 24.2 ± 2.4, the aver-
age length of time working in commercial sex was
2.4 years. The estimated percentage of FSW who were
married was 35.3 %, and 76.9 % had only completed junior
middle school education or below.
Disease burden of hepatitis
For studies conducted between 2000 and 2011, the esti-
mated overall HBV and HCV prevalence among FSW
were 10.7 % (95 % CI: 7.3–15.5 %) and 1.0 % (0.7–1.3 %)
(Table 1). Heterogeneities across the studies were sub-
stantial (HBV, p < 0.001; I2 = 97.1; HCV: p < 0.001; I2 =
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94.8). HBV disease burden varied substantially from
6.1 % (4.0–9.2 %) in the East to 15.5 % (9.5–24.2 %) in
the South Central (Fig. 1a). No included studies reported
HBV prevalence from FSW samples in the North and
Northwest. In contrast, the Northwest had the lowest
HCV prevalence (0.5 % [0.2–1.6 %]); while Southwest
was the highest (2.0 % [1.1–3.6 %], Fig. 1a). The tem-
poral trends of both of them were not significant (P >
0.05). Compared to the general Chinese population,
FSW had notably higher risk of HBV and HCV infection
Fig. 1 a. Estimated prevalence of sexually transmitted infections including Hepatitis B and C virus among female sex workers in six Chinese regions
during 2000–2011. *Only infection with > 10 papers were included, so the analysis excluded HPV because there are only four papers being found.
b. Level of disease burden among female workers across the six regions in China during 2000–2011 (high, moderate and low prevalence represent the
top, middle and bottom one-third of prevalence ranking among the six Chinese regions). *Only infection with > 10 papers were included, so the analysis
excluded HPV because there are only four papers being found
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(HBV: OR = 1.8 [1.6–1.9]; HCV: OR = 8.0 [3.6–17.8])
(Table 1).
Disease burden of sexually transmitted infections
Meta-analysis indicated that the most common STI among
FSW was HPV, with a pooled prevalence of 27.0 % (10.1–
55.1 %). Notably, genotype HPV16 (14.1 % [4.1–38.4 %])
was the most frequently identified sub-type. About 23.6 %
(6.1–59.5 %) of FSW were infected with multiple HPV sub-
types. HSV-2 ranked second reaching 15.8 % (11.7–20.9 %)
during 2000–2011, followed by Chlamydia at 13.7 % (12.1–
15.4 %). Subgroup analyses indicated that Chlamydia preva-
lence substantially varied by anatomical sites, ranging from
13.6 % (11.7–15.7 %) checked by cervical smear to 36.8 %
(19.6–58.2 %) checked by vaginal swab. The pooled preva-
lence estimates of syphilis, genital warts and Trichomonas
vaginitis were 5.2 % (4.8–5.7 %), 3.3 % (2.5–4.2 %) and
2.1 % (1.5–24.2 %), respectively (Additional file 1: Table S2).
Risk of STIs among FSW was far higher than in the gen-
eral population. The odds ratio (OR) for having genital
warts among FSW was 81.4 (40.6–163.2) compared to the
general population. This was followed by gonorrhoea (OR
40.3 [13.0–125.2]) and syphilis (OR 14.9 [10.9–20.4])
(Table 1). The prevalence of STIs was also higher among
HIV-infected FSW compared to boarder FSW. Based on
available data among HIV-positive FSW, prevalence of
HSV-2, Chlamydia, Trichomonas vaginitis and syphilis
were 83.2 % (75.6–88.8 %), 20.2 % (14.3–27.7 %), 19.7 %
(12.3–30.2 %) and 15.2 % (8.3–26.4 %), respectively. These
corresponded to 27.2 (17.0–43.5), 2.2 (1.4–3.3), 11.5 (5.7–
23.0) and 4.1 (2.8–6.0) higher risk comparing to the
broader FSW population (Table 2).
Temporal and geographical trend of STIs
Among sampled FSW, several STIs demonstrated a tem-
poral declining trend. Over the study period (2000 to
2011), reports of Chlamydia declined from 16.9 % (6.6–
35.1 %) in 2000–2002 to 10.7 % (7.7–14.9 %) in 2009–
2011 (p = 0.02) while reports of syphilis declined from
8.4 % (4.9–14.4 %) to 4.1 % (3.2–5.5 %) (p < 0.01). The
Table 1 Comparison of sexually transmitted infections prevalence between female sex workers and general female population in China
Type of infection No. of studies
(No. of data points)
Total No of infection/
Sample size
Pooled prevalence
among FSW (95 % CI)
Background prevalence among
general population (95 % CI)
Odds ratio (95 % CI)
HBV 18 (24) 848/7,614 10.71 (7.30–15.48) 6.40 (4.45–9.08)* [26] 1.75 (1.60–1.92)
HCV 97 (149) 1,366/114,722 0.96 (0.73–1.25) 0.12 (0.05–0.27)* [20] 7.99 (3.58–17.83)
Syphilis 215 (377) 13,507/245,455 5.24 (4.83–5.69) 0.37 (0.20–0.65)* [21] 14.89 (10.86–20.40)
HSV-2 38 (57) 9,529/30,345 15.77 (11.74–20.85) 5.80 (3.82–7.78)* [22] 3.05 (2.12–4.39)
Trichomonas vaginitis 43 (65) 2,271/24,381 2.12 (1.46–24.21) 2.52 (1.92–3.31)** [22] 0.83 (0.51–1.35)
Chlamydia 96 (125) 7,983/56,548 13.66 (12.11–15.37) 2.60 (1.60–4.10)** [23] 5.95 (4.42–8.01)
Cervix 41 (78) 5,503/33,231 13.56 (11.65–15.73) – –
Vaginal 3 (4) 402/872 36.80 (19.56–58.23) – –
PCR 48 (74) 5,839/31,695 15.48(13.70–17.45) – –
Rapid test 16 (19) 2,144/24,853 10.28(8.20–12.83) – –
Gonorrhea 116 (149) 3,723/62,430 6.07 (5.29–6.95) 0.16 (0.06–0.39)** [23] 40.32 (12.99–125.18)
Cervix 51 (74) 2,523/33,493 6.88 (5.68–8.31) – –
Vaginal 7 (9) 311/1,806 12.69 (7.52–20.60) – –
PCR 28 (55) 2,015/23,179 8.33(6.83–10.13) – –
Culture 52 (64) 1,417/28,143 5.62(4.51–6.97) – –
Wart 68 (76) 1,111/39,862 3.27 (2.53–4.21) 0.06 (0.01–0.07)** [20] 52.96 (26.42–106.15)
HPV (any) 4 (4) 531/1,631 27.04 (10.07–55.09) 16.80 (16.50–17.10)** [24] 1.84 (1.64–2.06)
Gene type 16 3 (3) 142/1,143 14.08 (4.13–38.40) 3.62 (0.82–14.62)* [61, 62] 4.39 (3.20–6.03)
Gene type 52 3 (3) 150/1,143 12.53 (6.36–23.30) 2.62 (1.75–3.48)* [61, 62] 5.32 (3.72–7.63)
Gene type 58 2 (2) 115/1,098 12.12 (2.65–41.11) 1.59 (1.07–2.36)* [61, 62] 8.60 (5.53–13.38)
Gene type 33 3 (3) 75/1,143 8.25 (2.61–23.19) 1.04 (0.63–1.72)* [61, 62] 8.48 (4.96–14.48)
Gene type 31 2 (2) 59/1,098 5.05 (3.84–42.25) 2.09 (1.44–3.02)* [61, 62] 2.46 (1.58–3.82)
Multiple type 2 (2) 216/1,098 23.57 (6.08–59.47) – –
Single type 2 (2) 328/1,098 29.9(27.3–32.7) – –
* refers to p < 0.05
** refers to p < 0.01
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average annual decline in prevalence of chlamydia and
syphilis were 9 % (1–16 %) and 2 % (0–5 %) respectively
(Fig. 2). Temporal trends of other STIs did not show sig-
nificant variations.
Southern Chinese regions had greater risk of STIs. In
particular, FSW in the Southwest had high prevalence of
HSV-2 (41.8 % [35.3–38.7 %]), Chlamydia (19.0 % [15.8–
22.6 %]) and Trichomonas Vaginitis (11.8 % [9.1–15.2 %])
(Fig. 1a). The South Central region shared a similar dis-
ease burden of STIs as seen in the Southwest but had the
highest nationwide prevalence of syphilis and genital warts
(8.3 % [7.0–10.0 %] and 4.0 % [2.6–6.3 %], respectively).
Prevalence of gonorrhoea among FSW was highest in the
North (12.7 % [7.5–20.6 %]) and East (6.9 % [5.7–8.3 %])
regions (Fig. 1a). Overall, the prevalence of most STIs
were low to moderate among FSW in the northern Chin-
ese regions (Fig. 1b).
Heterogeneities and risk of bias
Heterogeneities were significant in most of our meta-
analyses (Additional file 1: Table S2). Larger sample size
(≥400) tended to result in higher prevalence estimates
(in all STIs except HSV-2). Prevalence of syphilis (8.0 %
[7.4–10.1 %]), Trichomonas Vaginitis (13.2 % [7.9–
21.1 %]) and gonorrhoea (7.9 % [5.9–10.6 %]) were sub-
stantially higher among FSW sampled from detention
centres than among those sampled from entertainment
venues (p < 0.05). Study quality score was not associated
with prevalence estimates for any infections except
HSV-2 (Additional file 1: Table S2).
Discussion and conclusions
This meta-analysis has consistently demonstrated higher
STI and viral hepatitis burden among FSWs in South Cen-
tral and Southwest China compared to other Chinese re-
gions. Compared with a previous similar systematic review
[17], our study represents a significant extension in the in-
vestigation of temporal and geographical trend of STIs
among FSW in reference to the general population. Apart
from chlamydia and syphilis, prevalence levels of most
STIs and hepatitis infections remain stable over the studied
period. Compared with the general Chinese population,
FSW had a significantly higher risk of STI and hepatitis
infection. Similarly, HIV-positive FSW were more likely to
have STIs than the broader FSW population.
Our study reported a national HBV prevalence of 10.7 %
(HBsAg active) among Chinese FSW but with distinct re-
gional differences. This prevalence level is higher than that
of the general Chinese population (7.9 % in 2010, [26])
and the prevalence (7.18 %) reported by China CDC in
2006 [27]. Among all Chinese regions, the finding that
South Central China (15.5 %) has shown the highest
prevalence is consistent with the prevalence in the general
Chinese population [13, 19]. HBV transmission in China
is primarily through mother-to-child transmission [28,
29], but transmission by sex and injection sharing has also
been reported in high-risk population groups [29]. The
high HBV disease burden in Southern China is likely due
to earlier onset of both the epidemic [30–32]. Also of
note, China’s national HBV vaccination programme for
newborns was only introduced in 1992 [33]; many of our
studied subjects (average age 24.2) may have been born
before the start or scale-up of the vaccination program.
Vertical transmission may be the dominant route of trans-
mission of HBV in FSW, but high risk sexual behaviours
of FSW has also substantially added to the risk of HBV in-
fection in comparison with the general Chinese females.
Targeted interventions, orchestrated by China CDC and
local NGOs, should be implemented in FSW to improve
awareness and reduce further HBV transmission via sex-
ual means and vertical transmission.
Southwest China has reported the highest prevalence
of HCV (2.0 %). Southwest China has faced illicit drug
trafficking issues due to its close proximity bordering
the ‘golden triangle’, a well-known area for heroin pro-
duction, manufacture and distribution in Southeast Asia
[13]. It hosts estimated 3 million PWID and provides
42.7 % global seizures in heroin in 2013 [34]. Prevalent
injection drug use may be the underlying reason for
HCV transmission among FSW given that sexual trans-
mission via heterosexual sex is rare [14, 35]. Among
FSWs who use drugs, selling sex for drugs is notably
more common in southern China than others regions
[36, 37]. In order to alleviate the disease burden of
HCV, specialised behavioural interventions for FSW with
overlapping injecting and risk sexual behaviours should
be designed and implemented.
Table 2 Comparison of sexually transmitted infections prevalence between HIV-positive female sex workers and general female sex
workers in China
Type of infection No. of studies
(No. of data points)
Total No of infection/
Sample size
Pooled prevalence among
HIV-positive FSW (95 % CI)
Pooled prevalence
among FSW (95 % CI)
Odds ratio (95 % CI)
Chlamydia 2 (2) 28/139 20.21 (14.33–27.72) 13.66 (12.11–15.37) 2.15 (1.42–3.26)
HSV-2 2 (2) 107/128 83.22 (75.60–88.82) 15.77 (11.74–20.85) 13.6 (8.4–22.2)
Syphilis 5 (5) 27/210 15.22 (8.26–26.36) 5.24 (4.83–5.69) 4.13 (2.83–6.02)
Trichomonas vaginitis 1 (1) 15/76 19.74 (12.26–30.20) 2.12 (1.46–24.21) 11.48 (5.73–22.99)
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Fig. 2 (See legend on next page.)
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We noted a fall in the prevalence of both chlamydia
and syphilis over time. The fact that both of these infec-
tions are easily treatable and no significant fall has been
observed in other viral infections suggest that testing
and treatment of STIs either among sex workers or the
general community may be the principle factor affecting
their fall. On the other hand, syphilis is one of two STIs
under sentinel surveillance in China and acquiring more
attention from the local CDC. Thus the variation may
be attributable to policy changes related to the scaling-
up of syphilis testing in pregnancy [38] and as part of
the 2010–2020 syphilis control plan [39]. Building on
declines in chlamydia and syphilis, continued interven-
tion efforts are needed to achieve a decrease in viral in-
fections as well.
HPV is the most prevalent STI among Chinese FSWs
(27.0 %), as well as in the general Chinese population
(16.8 %, [24]). Further, HPV prevalence among Chinese
FSWs appears to be higher than that found in neighbour-
ing countries (22.9 % in Thailand [40] and 14.4 % in
Singapore [41]), a finding also true for genital warts: 3.3 %
in Chinese FSW versus 0.2 % in neighbouring Vietnam
[42]. Genital warts are mostly caused by infection with
HPV-6 or 11 [43, 44], but more virulent types of HPV
(type 16 and 18) are major risk factors for cervical cancers
in Chinese women [24, 45, 46]. Co-infection with HPV is
also known to facilitate the transmission of chlamydia,
gonorrhoea, HSV-2 and HIV [47]. Despite the evidence
that early vaccination before sexual debut dramatically re-
duces the risk of HPV infection, genital warts and cervical
cancers among females [48–50], currently there is no na-
tional HPV vaccination programme and no specific pre-
vention method for women of reproductive age in China
[51]. The majority of Chinese women (approximately
70 %) have no knowledge about HPV vaccines [52] and
even lower levels of knowledge and awareness of HPV in
FSW [53, 54]. Given the very high disease burden of HPV,
Chinese FSW should be regarded as a priority population
for HPV prevention and treatment, especially FSW who
are of reproductive age.
A number of limitations should be noted. First, we re-
ported high heterogeneities in our meta-analyses. Despite
the efforts of subgroup analysis and meta-regression, sig-
nificant heterogeneities were still present in subgroups. We
have analysed the influences of geographical region, recruit-
ment venue, sample size, publication language, study qual-
ity score, and year of publication. Second, statistical power
in subgroup analysis was often restricted by the limited
number of available studies, especially among the small
number of studies from the Northeast. Third, although we
only included studies diagnosed with the same method-
ology, the diagnostic accuracy of tests maybe improved dur-
ing the study period, so part of the declining trend in
prevalence may be owing to the improvement of technol-
ogy. Fourth, publication bias in the publication language
was significant. Fifth, the different clinical diagnostic stan-
dards of STIs and hepatitis infections may result in uncer-
tainties in sensitivity and specificity of results.
Our findings illustrated above are consistent with previ-
ous reports [7, 55–58]. We have extended the previous lit-
erature by quantifying these risks in a systematic manner to
demonstrate the urgency for appropriate prevention and
treatment strategies among Chinese FSW, especially those
co-infected with HIV. Health resources should be aligned
to address these issues. Prevalence of hepatitis infection
and STIs in Chinese FSWs is high but stable during the
study period 2000–2011. The high prevalence of STIs may
relate to the illegal status of sex work. Ongoing research in-
dicates that countries with either regulated or legalized sex
work have seen substantial falls in the prevalence of STIs in
sex workers, as a result of governments’ initiatives for wide-
spread condom programs and promotion of HIV testing
and treatment [59, 60]. China is unlikely to legalize sex
work in the near future, therefore comprehensive interven-
tions and HIV programs for FSWs through community-
based organizations should be promoted and prioritised.
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